SESANION Stock Latest News
Company AnnouncementsSaniona Files IND for Rapid-Acting Depression Drug SAN24651w ago
Company AnnouncementsSaniona advances SAN2465 as oral rapid-acting antidepressant with new preclinical data2w ago- Company AnnouncementsSaniona maps out busy 2026 conference schedule to showcase neurology pipeline3w ago
- Company AnnouncementsSaniona Calls Extraordinary Meeting to Seek Fresh Issuance Mandate3w ago
Company AnnouncementsSaniona readies IND filing for rapid-acting oral antidepressant SAN24651M ago
Company AnnouncementsSaniona Narrows R&D Focus as Losses Widen but Cash Position Strengthens2M agoCompany AnnouncementsAstronauTx Takes Global Rights to Saniona Neurology Program as ATX0926 Moves Toward Clinic2M ago
- Company AnnouncementsSaniona launches virtual R&D Day to spotlight SAN2668 for severe pediatric epilepsies5M ago
Company AnnouncementsSaniona shareholders block pay report as board pulls capital and incentive proposals5M ago
Company AnnouncementsSaniona Deepens Losses but Bolsters Cash as Pipeline Nears Clinic5M ago- Company AnnouncementsSaniona Schedules Q1 Investor Call Amid Advancing CNS Pipeline5M ago
Company AnnouncementsSaniona Publishes Comprehensive 2025 Annual Report Covering Operations, Financials and Governance6M agoCompany AnnouncementsSaniona convenes 2026 AGM with governance and long-term incentive plan on agenda6M ago
Company AnnouncementsSaniona Shifts From Partnership-Driven Gains to Clinical Execution in 20258M ago- Company AnnouncementsSaniona Sets February Investor Call to Present Q4 Results and Pipeline Update8M ago
Company AnnouncementsSaniona Strengthens Leadership to Advance CNS Programs10M ago
Company AnnouncementsSaniona AB Strengthens CNS Therapy Pipeline with Strategic Partnerships11M ago
Company AnnouncementsSaniona Announces Q3 Investor Call for 27 November 202511M ago